Calvin Sandra — SEC Form 4 filings

SEC reporting owner CIK 1882909. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-01-25 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Travere Therapeutics, Inc. (TVTX)SVP, CHIEF ACCOUNTING OFFICER1319 legs · 198,449 sh · $6,146,58441

Form 4 filings — Calvin Sandra

FiledFormIssuerReported transactionsSource
2026-09-174Travere Therapeutics, Inc. (TVTX)Option exercise (M): 2,500 @ $27.50 · Option exercise (M): 1,250 @ $22.40 · Option exercise (M): 1,625 @ $20.46 · Sale (S): 4,275 @ $62.13 · Sale (S): 800 @ $62.85 · Sale (S): 300 @ $63.66 · +3 moreEDGAR
2026-04-164Travere Therapeutics, Inc. (TVTX)Option exercise (M): 2,500 @ $22.40 · Option exercise (M): 6,250 @ $8.93 · Option exercise (M): 6,500 @ $20.46 · Sale (S): 21,977 @ $41.07 · Option exercise (M): 2,500 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0 · +1 moreEDGAR
2026-02-034Travere Therapeutics, Inc. (TVTX)Grant/award (A): 15,180 @ $0 · Sale (S): 4,333 @ $32.12 · Grant/award (A): 20,160 (derivative) @ $0EDGAR
2025-12-294Travere Therapeutics, Inc. (TVTX)Sale (S): 7,402 @ $40EDGAR
2025-12-164Travere Therapeutics, Inc. (TVTX)Sale (S): 2,910 @ $36EDGAR
2025-11-064Travere Therapeutics, Inc. (TVTX)Option exercise (M): 10,000 @ $25.25 · Option exercise (M): 17,500 @ $26.88 · Option exercise (M): 15,000 @ $27.50 · Option exercise (M): 12,500 @ $22.40 · Option exercise (M): 6,250 @ $8.93 · Sale (S): 67,115 @ $36 · +5 moreEDGAR
2025-02-124Travere Therapeutics, Inc. (TVTX)Option exercise (M): 10,000 @ $16.23 · Sale (S): 10,000 @ $25 · Option exercise (M): 10,000 @ $17.44 · Sale (S): 10,000 @ $25 · Option exercise (M): 10,000 @ $17.96 · Sale (S): 10,000 @ $25 · +7 moreEDGAR
2025-02-044Travere Therapeutics, Inc. (TVTX)Grant/award (A): 13,000 @ $0 · Sale (S): 3,348 @ $20.12 · Grant/award (A): 26,000 (derivative) @ $0EDGAR
2025-01-234Travere Therapeutics, Inc. (TVTX)Sale (S): 925 @ $18.94EDGAR
2024-12-274Travere Therapeutics, Inc. (TVTX)Option exercise (M): 15,000 @ $12.67 · Sale (S): 15,000 @ $17.22 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2024-11-254Travere Therapeutics, Inc. (TVTX)Option exercise (M): 15,000 @ $12.67 · Sale (S): 12,090 @ $18.30 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2024-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 12,500 @ $0 · Grant/award (A): 1,000 @ $0 · Sale (S): 2,820 @ $8.53 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2024-01-254Travere Therapeutics, Inc. (TVTX)Sale (S): 910 @ $9.07EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1882909 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →